Biotechnology is expected to play an important role in progress of life science and health medical science; moreover, it could solve the problems of current society such as of aging society, environment, food and energy. Responding to the expected drastic expansion of bio-diagnosis market, it is critical for PSS to take strategic measures in handling intellectual property rights including patents. In this context, PSS has established Universal Bio Research Co., Ltd. that handles intellectual property right strategically.
Universal Bio Research Co., Ltd. (UBR)
Since its establishment in July 2002, Universal Bio Research Co., Ltd. (UBR) has been managing the intellectual property rights of the PSS group collectively. In addition, after organizational reformation in July 2009, it has taken on the R&D activities for the PSS group. UBR, concentrating on systemization and collaborating with outsider professional institutions who have advanced/established technologies, bio-information, reagents, etc., is developing several types of fully automated analyzers one of which comleted all processes of genetic analysis from DNA extraction to detection, the other handles the protein analysis with PSS original detection method. By collaborating with outside partner, PSS seeks effective and speedy commercialization of new products
*UBR owns patent rights of all patents made by research and development in the PSS group. In addition, it aims at efficient use of patents needed for the PSS business growth, by purchasing promising patents from external companies. On the other hand there may be PSS patents not usable in own business, and in such a case, the patents should be licensed to external companies.